PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer

  1. Rischin, D.
  2. Gil-Martin, M.
  3. González-Martin, A.
  4. Braña, I.
  5. Hou, J.Y.
  6. Cho, D.
  7. Falchook, G.S.
  8. Formenti, S.
  9. Jabbour, S.
  10. Moore, K.
  11. Naing, A.
  12. Papadopoulos, K.P.
  13. Baranda, J.
  14. Fury, W.
  15. Feng, M.
  16. Stankevich, E.
  17. Li, J.
  18. Yama-Dang, N.A.
  19. Yoo, S.-Y.
  20. Lowy, I.
  21. Mathias, M.
  22. Fury, M.G.
Revue:
Gynecologic Oncology

ISSN: 1095-6859,  0090-8258

Année de publication: 2020

Volumen: 159

Número: 2

Pages: 322-328

Type: Article

DOI: 10.1016/J.YGYNO.2020.08.026 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus